OBJECTIVES: Penile cancer is a disease with a high morbidity and mortality. Its prevalence is relatively rare, but the highest in some developing countries. Insight into its precursor lesions, pathogenesis and risk factors offers options to prevent this potentially mutilating disease. This review presents an overview of the different histologically and clinically identified precursor lesions of penile cancer and discusses the molecular pathogenesis, including the role of HPV in penile cancer development. METHODS: A systematic review of the literature evaluating penile carcinogenesis, risk factors and molecular mechanisms involved. RESULTS: Careful monitoring of men with lichen sclerosis, genital Bowen's disease, erythroplasia of Queyrat and bowenoid papulosis seems useful, thereby offering early recognition of penile cancer and, subsequently, conservative therapeutic options. Special attention is given to flat penile lesions, which contain high numbers of HPV. Their role in HPV transmission to sexual partners is highlighted, but their potential to transform as a precursor lesion into penile cancer has been unsatisfactorily explored. CONCLUSIONS: Further research should not only focus on HPV mediated pathogenic pathways but also on the non-HPV related molecular and genetic factors that play a role in penile cancer development. Options for prevention of penile cancer include (neonatal) circumcision, limitation of penile HPV infections (either by prophylactic vaccination or condom use), prevention of phimosis, treatment of chronic inflammatory conditions, limiting PUVA treatment, smoking cessation and hygienic measures.
OBJECTIVES: Penile cancer is a disease with a high morbidity and mortality. Its prevalence is relatively rare, but the highest in some developing countries. Insight into its precursor lesions, pathogenesis and risk factors offers options to prevent this potentially mutilating disease. This review presents an overview of the different histologically and clinically identified precursor lesions of penile cancer and discusses the molecular pathogenesis, including the role of HPV in penile cancer development. METHODS: A systematic review of the literature evaluating penile carcinogenesis, risk factors and molecular mechanisms involved. RESULTS: Careful monitoring of men with lichen sclerosis, genital Bowen's disease, erythroplasia of Queyrat and bowenoid papulosis seems useful, thereby offering early recognition of penile cancer and, subsequently, conservative therapeutic options. Special attention is given to flat penile lesions, which contain high numbers of HPV. Their role in HPV transmission to sexual partners is highlighted, but their potential to transform as a precursor lesion into penile cancer has been unsatisfactorily explored. CONCLUSIONS: Further research should not only focus on HPV mediated pathogenic pathways but also on the non-HPV related molecular and genetic factors that play a role in penile cancer development. Options for prevention of penile cancer include (neonatal) circumcision, limitation of penile HPV infections (either by prophylactic vaccination or condom use), prevention of phimosis, treatment of chronic inflammatory conditions, limiting PUVA treatment, smoking cessation and hygienic measures.
Authors: Rachel L Winer; James P Hughes; Qinghua Feng; Sandra O'Reilly; Nancy B Kiviat; King K Holmes; Laura A Koutsky Journal: N Engl J Med Date: 2006-06-22 Impact factor: 91.245
Authors: J J Carter; M M Madeleine; K Shera; S M Schwartz; K L Cushing-Haugen; G C Wipf; P Porter; J R Daling; J K McDougall; D A Galloway Journal: Cancer Res Date: 2001-03-01 Impact factor: 12.701
Authors: Lance C Pagliaro; Dallas L Williams; Danai Daliani; Michael B Williams; William Osai; Michael Kincaid; Sijin Wen; Peter F Thall; Curtis A Pettaway Journal: J Clin Oncol Date: 2010-07-12 Impact factor: 44.544
Authors: Marc Arbyn; Silvia de Sanjosé; Mona Saraiya; Mario Sideri; Joel Palefsky; Charles Lacey; Maura Gillison; Laia Bruni; Guglielmo Ronco; Nicolas Wentzensen; Julia Brotherton; You-Lin Qiao; Lynnette Denny; Jacob Bornstein; Laurent Abramowitz; Anna Giuliano; Massimo Tommasino; Joseph Monsonego Journal: Int J Cancer Date: 2012-07-02 Impact factor: 7.396
Authors: L F Araujo; A T Terra; C T G Sares; C F R Sobreira; E F Faria; R D Machado; A A Rodrigues; V F Muglia; W A Silva; R B Reis Journal: Mol Biol Rep Date: 2018-06-12 Impact factor: 2.316
Authors: Miklós Damásdi; Ferenc Jakab; Krisztina Kovács; Miklós Oldal; Gábor Kemenesi; Eszter Szabó; István Vályi-Nagy; Ákos Pytel; László Farkas; Árpád Szántó Journal: Pathol Oncol Res Date: 2015-12-10 Impact factor: 3.201
Authors: Kelvin A Moses; Andrew Winer; John P Sfakianos; Stephen A Poon; Matthew Kent; Melanie Bernstein; Paul Russo; Guido Dalbagni Journal: Can J Urol Date: 2014-04 Impact factor: 1.344
Authors: Alan G Nyitray; Mihyun Chang; Luisa L Villa; Roberto J Carvalho da Silva; Maria Luiza Baggio; Martha Abrahamsen; Mary Papenfuss; Manuel Quiterio; Jorge Salmerón; Eduardo Lazcano-Ponce; Anna R Giuliano Journal: J Infect Dis Date: 2015-02-03 Impact factor: 5.226